New Saliva Test Shows Promise for Early Prostate Cancer Detection

Research indicates at-home spit tests could be more accurate than current blood tests for identifying high-risk individuals.

Studies presented at the ASCO meeting suggest saliva tests outperform PSA blood tests in detecting aggressive prostate cancer.
The test identifies genetic variants linked to prostate cancer, offering a more accurate early assessment tool.
Researchers from the Institute of Cancer Research and Royal Marsden NHS Foundation Trust led the study involving over 6,000 men.
Preliminary findings show the saliva test results in fewer false positives and more accurate detection of aggressive cancers.
Further research is needed to confirm the effectiveness of the test before it can be widely implemented.